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Abstract
Background: Human cytomegalovirus (HCMV) uracil DNA glycosylase, UL114, is required for efficient viral DNA replication.
Presumably, UL114 functions as a structural partner to other factors of the DNA-replication machinery and not as a DNA
repair protein. UL114 binds UL44 (HCMV processivity factor) and UL54 (HCMV-DNA-polymerase). In the present study we
have searched for cellular partners of UL114.
Methodology/Principal Findings: In a yeast two-hybrid screen SMARCB1, a factor of the SWI/SNF chromatin remodeling
complex, was found to be an interacting partner of UL114. This interaction was confirmed in vitro by co-
immunoprecipitation and pull-down. Immunofluorescence microscopy revealed that SMARCB1 along with BRG-1,
BAF170 and BAF155, which are the core SWI/SNF components required for efficient chromatin remodeling, were present
in virus replication foci 24–48 hours post infection (hpi). Furthermore a direct interaction was also demonstrated for
SMARCB1 and UL44.
Conclusions/Significance: The core SWI/SNF factors required for efficient chromatin remodeling are present in the HCMV
replication foci throughout infection. The proteins UL44 and UL114 interact with SMARCB1 and may participate in the
recruitment of the SWI/SNF complex to the chromatinized virus DNA. Thus, the presence of the SWI/SNF chromatin
remodeling complex in replication foci and its association with UL114 and with UL44 might imply its involvement in
different DNA transactions.
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Introduction
The human cytomegalovirus (HCMV), a member of the
Betaherpesviridae, is an important human pathogen. It is the major
viral cause of birth defects [1,2] and represents a major medical
problem in immunocompromised individuals, such as AIDS
patients and patients with allogenic solid organ or stem cells
transplants [3–5].
The HCMV-genome is one of the largest human DNA-virus
genomes (230 kbp) with about 200 predicted open reading frames [6].
After binding of HCMV to cell surface receptors the virus membrane
and cell membrane fuse, and the nucleocapsid is released into the
cytoplasm. The nucleocapsid transverses the cytoplasm by association
with the microtubules network and gain access to the nuclear pores
where the uncoating iscompleted and the viral genome is released into
the nucleoplasm [7]. Immediately after entering the nucleoplasm the
viral DNA is circularized, histone proteins bind to virus DNA and
nucleosomes are formed [8,9]. The HCMV genomes serve as
templates for transcription and replication, thought to take place
within discrete nuclear inclusions. These inclusions develop adjacent
to small sites known as promyelocytic leukemia bodies or nuclear
domain 10 and take over large parts of the nuclear space at late times
post infection [10,11]. HCMV replication requires a conserved set of
six core DNA replication proteins: the DNA polymerase (UL54) and
the associated polymerase processivity factor (UL44), a single-stranded
DNA binding protein (SSB; UL57), and the triplex containing DNA
helicase (UL105), primase (UL70) and primase-associated factor
(UL102) subunits [6,12,13]. HCMV UL114 encodes a uracil-DNA
glycosylase homolog that is highly conserved in all characterized
herpesviruses that infect mammals [14]. Analysis of HCMV-DNA
replication kinetics performed using a HCMV UL114 deletion
mutant has shown that the initial rate of DNA synthesis and the
accumulation of progeny viral genomes were significantly reduced
compared to the parent virus [15,16]. UL114 is thus obviously of
importance for several steps in HCMV-DNA synthesis.
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genomes is thought to be linked to the replication mechanisms
and life cycle of the virus [17]. Modifications of the chromatin
structure on HCMV-DNA are thus of importance both for
transcription, replication and regulation of latency [18–21]. The
chromatin structure on DNA is modified by post-translational
modification, e.g. acetylation and methylation of N-terminal tails
of histone proteins and by chromatin remodeling [22–24]. There
are currently four different families of chromatin remodeling
complexes; SWI/SNF (switching defective/sucrose non-ferment-
ing), ISWI (imitation switch), CDH (chromo domain helicase
DNA-binding) and INO80 (inositol requiring 80) family [23,25].
These ATP dependent chromatin remodeling complexes work in
concert with histone tail modifying enzymes [24].
In order to elucidate the mechanisms of UL114 mediated
enhancement of HCMV-DNA-replication we have searched for
cellular partners to UL114 by a two-hybrid assay. One of the
clones identified by sequencing was the human SMARCB1
protein, a core subunit of the highly conserved multi subunit
SWI/SNF chromatin remodeling complex. In this work we
characterized the intracellular localization of SMARCB1 through-
out infection showing re-localization to the replication foci.
Further experiments showed direct interaction of SMARCB1
and UL114 and SMARCB1 and UL44.
Results
Yeast two-hybrid experiments identify the cellular factor
SMARCB1 as a strong binding partner to UL114
To identify cellular partners of the HCMV encoded uracil DNA
glycosylase, UL114, we used a yeast based two-hybrid system with a
‘‘bait’’ plasmid (pGBKT7-UL114) encoding the full-length UL114
protein fused to GAL4 DNA-binding domain (BD) in pGBKT7
transformed into the yeast strain AH109. The two-hybrid screen
was performed by mating a yeast strain Y187 pre-transformed with
a highly complex brain cDNA library cloned into the yeast GAL4
activation domain (AD) vector pACT2 with AH109-pGBKT7-
UL114. Cells were grown on synthetic dropout (SD) medium; SD-
trp/-leu/-his/-ade, to select for strong interactions. More than 350
clones were found to grow under these strict conditions indicating
several putative cellular partners to UL114. All of these clones were
subjected to automated sequencing and homology searches in
NCBI databases. Because a large number of clones were screened,
several independent clones containing the same binding domain
were isolated in many cases. After sorting the sequencing data
eliminating typically false positives and taking into account clones
represented more than once, 17 clones were subjected to direct two-
hybrid analysis (Figure 1A). Self-activating clones were identified by
mating the 17 clones with the empty BD vector (pGBKT7) and
plating in selective media: 2leu/2trp/+his/+ade for cell viability
and 2leu/2trp/2his/2ade for self-activation (clones 2, 3, 5, 7, 8,
9, 10, 13 and 14; Figure 1A). One of the clones that did not self-
activate (clone 12, Figure 1A) was identified as a partial cDNA
encoding for human SMARCB1 (SNF5/INI1/BAF47) (379 aa
from accessory number NM_003073.2, Gene ID: 6598), termed
D379-SMARCB1 in this paper (Figure 1B). The specific interaction
between D379-SMARCB1 and UL114 was confirmed by direct
two-hybrid analysis with various controls (Figure 1C).
SMARCB1 and UL114 interact in vitro
In order to test whether the interaction between UL114 and
D379-SMARCB1 was reproducible in vitro, three sets of experi-
ments were performed. First, by coupled in vitro transcription/
translation and co-immunoprecipitation (IP), we examined the
interaction between the two proteins using [
35S]methionine-
labeled HA-tagged D379-SMARCB1 and [
35S]methionine-la-
beled c-myc-tagged UL114. IP with anti-HA antibody recovered
HA-D379-SMARCB1 and c-myc-UL114 (Figure 2A, lane 3).
Reciprocally, c-myc-UL114 and HA-D379-SMARCB1 were
detected when immunoprecipitation was performed with anti-c-
myc antibody (Figure 2A, lane 4). Control immunoprecipitations
with an irrelevant antibody and protein were carried out to
confirm the specificity of the interaction between D379-
SMARCB1 and UL114. Thus, c-myc-tagged UL114 was not
immunoprecipitated by the HA antibody (Figure 2A, lane 5) and
HA-tagged D379-SMARCB1 was not immunoprecipitated by the
c-myc antibody (Figure 2A, lane 6). Moreover, an independent
HA-tagged protein HA-clone 4 (clone 4 from Figure 1A) was not
immunoprecipitated by c-myc-UL114 (Figure S1).
Second, direct interaction studies between UL114 and
SMARCB1 were carried out using a glutathione S-transferase
(GST) pull-down assay. To this end, full-length SMARCB1 was
cloned into a bacterial GST expression vector and purified. GST
was also expressed; however the expression was so high that no
purification was needed for these experiments. GST-SMARCB1
or crude GST extract incubated with purified UL114 were
subjected to conventional pull-down analysis by the use of
glutathione (GST-binding) magnetic beads. After pull-down, the
samples were analyzed by western blotting using anti-UL114, anti-
SMARCB1 and anti-GST antibodies. Western blot results shown
in Figure 2B, indicated that UL114 bound to SMARCB1 directly.
Third, to investigate whether SMARCB1 and UL114 interacted
in vivo, human fibroblast cells were infected with HCMV. The
lysates were immunoprecipitated with anti-SMARCB1 antibodies.
Immunoprecipitation with SMARCB1 antibody clearly showed
input SMARCB1, however, we could not detect UL114 in the
precipitate (data not shown). As previously reported the reverse co-
immunoprecipitation experiment with UL114 antibodies was not
possible because the available UL114 antibody lacked immuno-
precipitation properties [26]. Thus, GST-SMARCB1 and GST
immobilized on GST-binding magnetic beads were incubated with
HCMV-infected cell lysates. After pull-down, the samples were
analyzed by western blotting using anti-UL114, anti-SMARCB1,
anti-GST and anti-UL57. As shown in Figure 2C, UL114 from
HCMV infected cells was found to interact robustly with GST-
SMARCB1 but not to GST alone. The specificity of the assay was
tested by blotting against UL57, the single-stranded DNA binding
protein. As seen in Figure 2C, UL57 was readily detected in the
HCMV lysate (lane 4), however, it was not precipitated with GST-
SMARCB1. These in vitro binding results confirm the yeast two-
hybrid interaction between UL114 and SMARCB1.
SMARCB1 is recruited to HCMV replication foci
As described previously the essential viral replication proteins
organize into discrete nuclear foci, termed pre-replication sites that
mature into viral DNA replication compartments [26,27]. UL44 is
recruited into pre-replication sites already at 5 hours post infection
(hpi), prior to the onset of DNA replication and can thus be used as
a HCMV replication focus marker [16,26]. We investigated
whether SMARCB1 was recruited to these sites during HCMV
infection by assessing intracellular localization of SMARCB1 in
mock and HCMV-infected fibroblast cells at immediate –early (5–
12 hpi), early (24 hpi) and late (48 and 72 hpi) time points of
infection. We showed that SMARCB1 was recruited to viral
replication foci in HCMV-infected cells and co-localized with
UL44 throughout the infection cycle (24–72 hpi) (Figure 3A). In
mock fibroblast cells the localization of SMARCB1 was hampered
by high background staining in contrast to HCMV infected
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visualize co-localization at immediate –early (5–12 hpi) time points
of infection were hampered by high background staining (data not
shown). Since only SMARCB1 and UL114 rabbit antibodies
functioning in immunofluorescence were available, co-localization
studies could not be carried out. However, previous results have
shown that UL114 localizes to viral replication foci as early as
5 hpi and co-localizes with UL44 throughout the infection cycle
(5–72 hpi) [26], thus indirectly indicating that SMARCB1 and
UL114 co-localize.
To investigate whether the entire 2 MDa multi SWI/SNF
complex or only the SMARCB1 protein was recruited to the viral
replication foci, we examined co-localization between UL44 and
three other proteins in the multi SWI/SNF complex; the central
ATPase subunit; Bramha-related gene-1 (BRG-1), BAF170 and
BAF155, which in addition to SMARCB1 are required for
efficient chromatin remodeling activity [28]. As shown in Figure 3B
they were all recruited into HCMV replication foci (48 hpi).
The expression of the core SWI/SNF chromatin
remodeling factors increase in HCMV-infected fibroblast
cells
The experiments shown in Figure 3 suggested that the
expression of SWI/SNF members tested increased during HCMV
infection. We first, analyzed the expression of SMARCB1, UL114
Figure 1. Direct yeast two-hybrid analysis of putative interacting partners of UL114. Two-hybrid screening of a brain cDNA library
(activation domain (AD)) using UL114 as a bait (binding domain (BD)) identified several potential interacting cellular partners. (A) 17 unique clones were
subjected to direct two-hybrid analysis. Self-activation of the reporter genes lacZ and HIS3 was tested for each of the 17 clones by co-transforming and
plating each of the putative interacting clones (interactors 1 to 17-AD) and the empty bait plasmid (empty-BD) on selective media: (2leu/2trp/+his/
+ade)forcellviabilityand(2leu/2trp/2his/2ade)forself-activation.Singlecoloniesdilutedinwater atequaldensitywerespottedontoselectivemedia
as indicated. Clones 1–11 and 13–17: interactor 1–11 and 13–17+BD-empty (pGBKT7); clone 12: AD-D379-SMARCB1+BD-empty (pGBKT7); clone 18:
positive control, AD-Tag+BD-p53. Clones 1, 4, 6, 11 and 12 did not self-activate. (B) Schematic presentation of wild type (wt) SMARCB1 and truncated
D379-SMARCB1 identified by the two-hybrid analysis (clone 12 from Figure 1A). Numbers indicate amino-acid residues. SMARCB1 has two highly
conserved domains (Rpt1 and Rpt2) that are imperfect direct repeats of each other and a third conserved coiled coil domain at the C terminus (CC). (C)
Extensive direct two-hybrid analysis of truncated SMARCB1 (D379-SMARCB1). Strong interaction was tested by co-transformation and plating of AD-
D379-SMARCB1+BD-UL114 on selective media (2leu/2trp/2his/2ade). Self-activation was tested by co-transformation and plating of AD-D379-
SMARCB1+BD-empty and AD-empty+BD-UL114 on selective media (2leu/2trp/2his/2ade). Four single colonies diluted into water at equal density
were spotted onto selective media as indicated. Positive control: AD-Tag+BD-p53, Negative control: AD-empty+BD-empty.
doi:10.1371/journal.pone.0034119.g001
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34119Figure 2. SMARCB1 and UL114 interact in vitro. (A) In vitro binding analysis of HA-tagged D379-SMARCB1 and c-myc-tagged UL114 in
35S-
labeled proteins using the TNT coupled transcription/translation system. The proteins were transcribed and translated in vitro with
35S-methionine in
the translation mixture to generate radioactive labeled products from vectors pACT2-D379-SMARCB1 (HA-epitope) and pGBKT7-UL114 (c-myc
epitope). The translated D379-SMARCB1-HA and UL114-c-myc were immunoprecipitated with either anti-HA or anti-c-myc-antibodies and eluted
from the Protein G beads. Samples were subjected to 8% SDS-PAGE and PhosphoImaging. Lane 1: UL114-c-myc+c-myc antibody. Lane 2: D379-
SMARCB1-HA+HA-antibody. Lane 3: D379-SMARCB1-HA+UL114-c-myc+HA-antibody. Lane 4: D379-SMARCB1-HA+UL114-c-myc+c-myc antibody.
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early (24 hpi) and late (48 and 72 hpi) times of infection. Results
showed that the expression of SMARCB1 increased in both mock
(72 hpi) and HCMV-infected cells (Figure 4A). Also, UL114 and
UL44 increased throughout the infection cycle according to
previously published data (Figure 4A) [26]. Next we examined
nuclear extracts at late (72 hpi) times of infection for the
expression of BRG1, BAF 170 and BAF 155. As seen in
Figure 4B, all three proteins showed higher expression in HCMV
infected cells compared to mock cells.
SMARCB1 and UL44 interact in vivo and in vitro
As co-localization studies indicated that SMARCB1 was
associated with the viral replication apparatus, experiments
investigating the interaction between SMARCB1 and UL44 were
undertaken. First, we performed experiments in which SMARCB1
was immunoprecipitated with anti-SMARCB1 antibody from cell
extracts prepared from HCMV-infected fibroblast cells. Western
blot analysis of the immunoprecipitated samples revealed the
presence of UL44 (Figure 5A, lane 2). UL44 could not be detected
in IP experiments with no antibody or from uninfected cells (mock)
(Figure 5A, lanes 3 and 1, respectively). The interaction between
SMARCB1 and UL44 could be mediated by UL114, other viral
and cellular proteins or DNA. We thus performed an experiment
with purified proteins to analyze if it was a direct interaction
between SMARCB1 and UL44. UL44 was cloned into a bacterial
His6 expression vector and purified. A His6 pull-down assay was
carried out using purified His6-UL44 immobilized to magnetic
beads with excess of purified GST-SMARCB1 and GST. His6-
UL44 was able to precipitate GST-SMARCB1 but not GST alone
(Figure 5B, lanes 3 and 6, respectively). The specificity of the
binding reaction assay was tested using His6-NEIL1 instead of
His6-UL44 as an irrelevant protein (Figure S3). We have thus
demonstrated a direct interaction between UL44 and SMARCB1.
Expression and sub-nuclear distribution of SMARCB1,
UL114, and UL44 in the nuclei of HCMV-infected
fibroblast cells
Biochemical and genetic evidence suggest that the SWI/SNF
complex is involved in the remodeling of chromatin during gene
activation [24,29,30]. Studies have shown that several components
of the SWI/SNF complex are enriched in active chromatin and
are associated with the nuclear matrix [31]. We therefore
examined the sub-nuclear localization of SMARCB1, UL114
and UL44 in mock and HCMV-infected fibroblasts at early
(24 hpi) and late (48) times of infection by biochemical
fractionation and western blot analysis. Extracts from mock-and
HCMV-infected cells were prepared to obtain the soluble
chromatin and the nuclear matrix and analyzed by western
blotting. The fractionation procedure was controlled by immuno-
blotting with antibodies directed against lamin A/C, a nuclear
matrix-associated protein, and histone H1, a chromatin-associated
protein. Immunoblotting (Figure 6) revealed that SMARCB1,
UL114 and UL44 were present in both the soluble chromatin and
nuclear matrix fractions of the HCMV-infected cells. Both mock-
and HCMV-infected cells showed highest enrichment of
SMARCB1 in the nuclear matrix fraction 48 hpi. The UL114
and UL44 proteins showed the highest enrichment in the
chromatin fraction and the expression increased 24–48 hours
after HCMV infection.
Discussion
Evidence from several studies indicates that the DNA genome of
herpesviruses is devoid of any nucleosomes within the virus
particle [32–34]. In contrast, in infected nuclei, herpesvirus
genomes form structures that resemble cellular chromatin and
these structures change in composition throughout the time course
of infection [35–38]. As early as two hours post infection, a
fraction of the HCMV genomes is associated with histones, but
eventually, the HCMV progeny genomes have to be stripped
naked before being packaged [9]. Factors involved in DNA
replication, repair and transcription do not get access to DNA
packed in chromatin and thus have to act in concert with
chromatin modifiers and remodelers that loosen the chromatin
grip on DNA. The SWI/SNF family of chromatin remodeling
complex utilizes the energy of ATP hydrolysis to remodel
chromatin structures, thereby participating in gene regulation,
replication, viral integration, control of cell growth and tumor
suppression [25,39]. SMARCB1 was initially identified as a
cellular partner to the HIV-1 integrase [40]. Subsequent studies
have revealed the interaction of SMARCB1 or other subunits of
the SWI/SNF complex with viral proteins from human papillo-
mavirus [41–43], Epstein-Barr virus [44], Kaposi’s sarcoma-
associated herpes virus [45] and herpes simplex virus 21 [46,47].
Collectively, these studies have shown that the SWI/SNF complex
is crucial for effective viral gene transcription and DNA
replication. In search for cellular partners of UL114, a nearly
full-length SMARCB1 clone was identified as an interacting
partner. The direct interaction between UL114 and SMARCB1
was validated in vitro by three different experiments.
UL114 has been found to interact with UL44 and this complex
was highly enriched in viral replication foci [16,26]. Since co-
localization between UL114 and SMARCB1 could not be carried
out, UL44 was used as a replication marker. By this mean we
showed that SMARCB1 co-localizes to replication foci as early as
24 hpi. The SWI/SNF complex consists of at least nine subunits
that are conserved among eukaryotes [48]. Four of the subunits;
the central ATPase subunit, either hBRM (Bramha) or Bramha-
related gene-1 (BRG-1), SMARCB1, BAF170 and BAF155 are
required for efficient chromatin remodeling [28]. Our results
demonstrate that the expression of these core subunits of the SWI/
SNF chromatin remodeling complex increased during HCMV
infection and were relocated to and concentrated in virus
replication foci of HCMV-infected fibroblasts. To our knowledge,
Lane 5: UL114-c-myc+HA-antibody. Lane 6: D379-SMARCB1-HA+c-myc-antibody. (
.......) indicates that samples were run on the same gel and (——)
indicates that samples were run on a different gel. (B) and (C) GST pull-down assays to detect the interaction of SMARCB1 and UL114. (B) Purified
GST-SMARCB1 or crude extract of E. coli cells over-expressing GST were incubated with purified UL114. The GST pull-down products were
immunoblotted with anti-SMARCB1, anti-UL114 and anti-GST. Lane 1: GST-extract+UL114. Lane 2: GST-SMARCB1+UL114. Lane 3: purified GST-
SMARCB1 (2 mg, 10% of input). Lane 4: Purified UL114 (1 mg, 5% of input). Note that spontaneous cleavage of GST occurred in the GST-SMARCB1
protein sample (Lanes 2 and 3). (C) Purified GST-SMARCB1 or crude extract of E. coli cells over-expressing GST were incubated with lysates of HCMV-
infected cells. The GST pull-down products were immunoblotted with anti-SMARCB1, anti-UL114, anti-GST and anti-UL57. Lane 1: GST-extract+HCMV
lysate. Lane 2: GST-SMARCB1+HCMV lysate. Lane 3: purified GST-SMARCB1 (2 mg, 10% of input). Lane 4: HCMV lysate (30 mg, 1% of input). Note that
spontaneous cleavage of GST occurred in the GST-SMARCB1 protein sample (Lanes 2 and 3). The asterisks (*) on Lanes 1 and 4 indicates unspecific
bands by the use of anti-SMARCB1.
doi:10.1371/journal.pone.0034119.g002
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detected in virus replication foci in HCMV. Furthermore,
interaction between SMARCB1 and UL44 was demonstrated
both by detection of SMARCB1 in cell extracts precipitated with
anti-UL44 antibodies and by direct interaction between recom-
binant proteins. Thus, we have evidence of direct interactions
between SMARCB1 and UL114 and SMARCB1 and UL44. The
UL44 and/or UL114 proteins may be of importance to recruit
and stabilize the SWI/SNF chromatin remodeling complex to the
replication centers.
The human HCMV DNA polymerase is composed of a
catalytic subunit, UL54, which possesses basal DNA polymerase
activity [49], and the accessory protein, UL44 which has been
shown to specifically interact with UL54 and to stimulate long-
chain DNA synthesis by UL54 [50,51]. UL44 is a multifunctional
protein capable of associating/interacting with several other viral
and host proteins [16,26,52–55]. Viral replication centers also
serve as foci for viral gene expression, presumably in part by
concentrating templates for transcription with the proteins that
carry out or regulate this process. Thus, the presence of the SWI/
SNF chromatin remodeling complex in replication foci throughout
infection and its association with UL114 and with UL44 might
imply its involvement in different DNA transactions. For example,
it has been shown that the UL44 gene product from the late viral
transcript is required for efficient viral gene expression rather than
viral DNA synthesis [56]. Comparable to the herpes simplex virus
type-1 single-strand DNA-binding protein, ICP8, which co-
precipitates with chromatin remodeling factors [47], UL44 could
recruit the SWI/SNF complex to late viral promoters at late times
after infection.
Finally, although controversial and ill-defined, the nuclear
matrix, also referred to as nucleoskeleton or scaffold, organizes the
eukaryotic DNA into topologically distinct loops. This is generated
by the attachment of chromatin fibers to the nuclear matrix via
specific regions called scaffold or matrix attachment regions S/
MAR [57,58]. DNA replication and transcription of active DNA
are found tightly associated with the nuclear matrix, while inactive
loci are not [59–61]. Several studies have reported replication and
expression of viral genomes in association with the nuclear matrix
[62–64]. SMARCB1 has been found to be associated with the
nuclear matrix and chromatin [31]. UL44 has also been shown to
be associated with the nuclear matrix [65]. By fractionating the
nucleus into the sub-nuclear structures; chromatin and nuclear
matrix, we showed that in addition to SMARCB1 and UL44,
UL114 was present in the chromatin and nuclear matrix fraction,
but highly enriched in the chromatin fraction. However, it remains
to be investigated whether SMARCB1, UL114 and UL44
associate in one complex and/or as different complexes (in the
nuclear matrix and/or associated with chromatin) throughout the
time course of infection allowing chromatin remodeling both
during DNA replication, DNA transcription and DNA packaging.
Materials and Methods
Cells and Virus
Human embryonic fibroblast (HE) cells were obtained from the
National Institute of Public Health, Oslo, Norway. HE-cells were
grown and maintained in 1:1 minimal essential medium
Figure 3. Recruitment of SWI/SNF chromatin remodeling
factors to nuclear virus DNA replication foci. (A) SMARCB1 co-
localizes with UL44 in HCMV-infected fibroblast cells harvested at 24,
48, and 72 hpi. (B) Co-localization of SMARCB1 and other essential
factors of the SWI/SNF complex; BRG-1, BAF155, BAF170, in HCMV
infected fibroblast cells harvested at 48 hpi. The cells were fixed and
subjected to double-staining for UL44 (mouse Mab-UL44) and
SMARCB1 (rabbit Pab-SMARCB1) and SMARCB1 (rabbit Pab-SMARCB1)
and either BRG-1 (mouse Mab-BRG-1), BAF155 (mouse Mab BAF155),
BAF170 (mouse Mab BAF170) for immunofluorescence microscopy.
Secondary antibodies were used for staining UL44, BRG-1, BAF155,
BAF170 in green (anti-mouse 488) and SMARCB1 in red (anti-rabbit
594), and the cells were further visualized by confocal microscopy. Co-
localization was visualized by a merge of the two microscopic
determinations, and counterstaining of the nuclei was achieved by
the use of DAPI.
doi:10.1371/journal.pone.0034119.g003
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(Gibco, LifeTechnologies Ltd. supplemented with endotoxin-free
fetal calf serum (FCS), L-glutamine (0.3 mg/ml), gentamicin
(40 mg/ml), amphotericin B (Fungizone) (2.5 mg/ml), and penicil-
lin G (6 mg/ml). Medium with 10% FCS was used for propagation
of the cells whereas medium with 2% FCS was used for
maintenance of the cells. The HE-cells were routinely screened
for mycoplasma by DNA staining with MycoAlert Mycoplasma
Detection kit (Lonza Rockland Inc.).
Stocks of highly purified human cytomegalovirus (HCMV)
laboratory type strain AD169 (American Type Culture Collection
(ATCC), Rockville, MD) was propagated in low passage HE cells.
Virus was propagated at low virus to cell ratios to minimize
generation of defective particles and purified as described
previously [66].
Cell cycle synchronization and infections
All cell experiments were performed subsequent to release from
contact inhibition. The cells were grown to confluence, and after
three days of confluence, they were trypsinized and re-plated at a
lower density (10
6cells/75 cm
2) to induce progression into the cell
cycle. At the time of re-plating (1:1 MEM+DMEM-10% FCS), the
cells were infected with HCMV at a multiplicity of infection (moi)
of 5 plaque forming unit (PFU) per cell or mock infected. Virus
adsorption was allowed for one hour before the medium was
discarded and fresh medium (1:1 MEM+DMEM-10% FCS) was
added. Only experiments where more than 95% of the cells were
infected were accepted. The infection was assessed at 24 hpi by an
immunocytochemical method employing E13 monoclonal anti-
bodies specific for IE1 and 2 antigens (Seralab UK).
Figure 4. Increased expression of the SWI/SNF core subunits in HCMV infected cells. (A) The expression of UL114, SMARCB1 and UL44 in
nuclear extracts (20 mg) from mock and HCMV-infected fibroblast cells was analyzed at immediate –early (12 hpi), early (24 hpi) and late (48 and
72 hpi) times of infection by western blot. The western blots were analyzed by Thyphoon scanning. GAPDH was used as a loading control. (B) The
expression of BRG1, BAF155 and BAF 170 in nuclear extracts (40 mg) from mock and HCMV-infected fibroblast cells was analyzed at late (72 hpi) time
of infection by western blot. The western blots were analyzed by Thyphoon scanning. GAPDH was used as a loading control.
doi:10.1371/journal.pone.0034119.g004
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for preparation of cell lysates or trypsinized for preparation of
nuclear extract or cytospins for immunostaining.
Preparation of cell lysates and nuclear extracts
Cells for preparation of cell lysates were harvested by scraping
cells into ice-cold PBS, followed by centrifugation at 10006g for
4 minutes at 4uC. Cell pellets were lysed using a modified RIPA
buffer (50 mM Tris-HCL, pH 7,4, 150 mM NaCl, 1 mM EDTA,
1% NP-40 (Igepal CA-630, Sigma-Aldrich), 1 mM PMSF and
Protease Inhibitor Cocktail (PIC) (P 8340, Sigma-Aldrich), and
incubated at 4uC for 15 minutes, followed by centrifugation at
140006g for 15 minutes at 4uC . The supernatants were decanted
into a fresh tube and stored at 270uC until used. Nuclear extracts
were made by plasmolysis of mock or HCMV-infected (5 PFU/
cell) fibroblast as previously described [66,67].
Figure 5. Interaction of SMARCB1 and UL44 in HCMV-infected fibroblast cells and with recombinant proteins. (A) Co-
immunoprecipitation of endogenous SMARCB1 and UL44 in HCMV-infected fibroblast cells. Equal numbers of mock infected and HCMV infected
fibroblast cells were lysed at 72 hpi, and the extracts were immunoprecipitated with anti-SMARCB1. Co-immunoprecipitated proteins were resolved
electrophoretically and subjected to immunoblot analysis with anti-UL44 and anti-SMARCB1. Lane 1: Mock lysate immunoprecipitated with anti-
SMARCB1. Lane 2: HCMV lysate immunoprecipitated with anti-SMARCB1. Lane 3: HCMV lysate immunoprecipitated with no antibody. Lanes 4 and 5,
SMARCB1 and UL44 input in extracts (7 mg, 1% of the total in Lane 4 and 35 mg, 5% of the total in Lane 5). IgGHc: IgG heavy chain. (B) In vitro pull-
down assay of GST-SMARCB1 and His6-UL44. Purified GST-SMARCB1 or GST incubated with purified His6-UL44 immobilized on magnetic His-tag
Dynabeads. Samples were analyzed by SDS-PAGE and Coomassie blue staining. Lane 1: GST-SMARCB1+Dynabeads His-tag. Lane 2: His6-
UL44+Dynabeads His-tag. Lane 3: GST-SMARCB1+His6-UL44+Dynabeads His-tag. Lane 4: His6-UL44 (2 mg, 10% of input). Lane 5: GST-SMARCB1 (2 mg,
10% of input). Lane 6: GST+His6-UL44+Dynabeads His-tag. Lane 7: GST (2 mg, 10% of input). Note that spontaneous cleavage of GST occurred in the
GST-SMARCB1 protein sample (Lane 5). (
……) indicates that samples were run on the same gel.
doi:10.1371/journal.pone.0034119.g005
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Nuclear matrix proteins were fractionated from the indicated
cells according to the method of He and collaborators (1990) [68].
Cells were washed twice in PBS and treated with 500 ml of CSK
buffer (10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose,
3 mM MgCl2, 1 mM EDTA, 1 mg/ml leupeptin and pepstatin,
1 mM PMSF and 0.1% Triton X-100) for 10 min on ice. The cells
were collected and centrifuged at 5000 g for 2 min. The soluble
cytoplasmic fraction was removed and the pellet resuspended in
200 ml of CSK buffer containing 100 U RNase-free DNase I
(Roche Diagnostics). After 15 min at 37uC, ammonium sulfate was
added to a final concentration of 0.25 M. The samples were
rotated 5 min at room temperature and centrifuged as above. The
soluble chromatin fraction was removed, the pellet washed in CSK
buffer with 2 M NaCl for 5 min at 4uC and centrifuged as above.
The supernatant was removed and the nuclear matrix pellet
resuspended in 100 ml3 6 Laemmli buffer and equal cell
equivalents from each fraction were subjected to conventional
western blot analyses.
Immunoprecipitation
750 mg of either mock or HCMV lysates incubated with 2.5 mg
of rabbit polyclonal SMARCB1 antibody (a kind gift from Dr.
Imbalzano, University of Massachusetts Medical School, US) or
750 mg of HCMV lysate without antibody were incubated for 1 h
at 4uC with gentle agitation. Immunocomplexes were precipitated
by the addition of Protein G beads (GE Healthcare Bio-Science
AB) and incubated for 2 h at 4uC. After sufficient washing with
modified RIPA buffer the immunoprecipitate was eluted in 16
Laemmli NuPage buffer by preheating to 70uC for 20 min and
separated by 10% Nupage SDS-PAGE and further subjected to
conventional western blot analysis.
Western blotting
Proteins were separated by using the NuPage system (10% gel)
(Invitrogen) as described by the manufacturer and electroblotted to
a polyvinylidene fluoride membrane (Immobilon-P/Immobilon-
FL, Millipore). Primary antibodies used were mouse anti-GST
((3D4), sc-57753, Santa Cruz Biotechnology), goat anti-lamin A/C
antibody (N-18, Santa Cruz Biotechnology), rabbit anti-histone
H1 antibody (FL-219, Santa Cruz Biotechnology), mouse anti-
UL57 ((anti-cytomegalovirus ICP8, CH167), ab-53493 Abcam),
rabbit anti-UL114 (polyclonal ascites/serum raised against a
synthetic peptide comprising amino-acids 11–28+cys of UL114),
mouse anti-UL44 (cat. No ABV006, Autogenbioclear), rabbit anti-
SMARCB1 (ab12167, Abcam), mouse anti-GAPDH (cat.
no. 4300, Ambion), mouse anti-BRG-1 ((G7), sc-17796 Santa
Cruz Biotechnology), mouse anti-BAF155 ((DXD7), sc-32763
Santa Cruz Biotechnology) and mouse anti-BAF170 ((E6), sc-
17838 Santa Cruz Biotechnology). Secondary antibodies were
peroxidase-conjugated anti-mouse or anti-rabbit IgG antibodies
(Promega). Membranes were visualized with the use of ECF-PLUS
(Amersham) and PhosphoImager (Molecular Dynamics).
Immunofluorescence microscopy
Cytospins with 10
5 cells were fixed with ice-cold methanol/
acetone (1:1) for 90 s and frozen at 270uC until use. Cytospins
were washed in TBS before incubation with primary and
secondary antibodies diluted in serum diluent (TBS with 12.5%
HCMV-negative serum). The cytospins were incubated at 4uC
over night with the primary antibodies; mouse monoclonal anti-
UL44 (2 mg/ml) (CA006-100, Virusys Corp.), rabbit anti-
SMARCB1 (5 mg/ml) (ab12617, Abcam), mouse anti-BAF155
(DXD7) (0,4 mg/ml) (sc-32763 Santa Cruz Biotechnology Inc.),
mouse anti-BAF170 (E-6) (0,4 mg/ml) (sc-17838 Santa Cruz
Biotechnology Inc.), mouse anti-BRG-1 (G-7) (0,4 mg/ml) (sc-
17796 Santa Cruz Biotechnology Inc.) before incubation with
secondary antibodies, anti-rabbit Alexa FluorH 594 f(ab9)2
(Molecular Probes A11072) and anti-mouse Alexa FluorH 488
f(ab9)2 (Molecular Probes A11070), for 1 hour at room tempera-
ture. The cover slips were mounted in Vectashield medium
containing Dapi (1.5 mg/ml) (Vector Laboratories) and analyzed
using a Zeiss LSM 510 META confocal microscope (636/1.4 NA
Plan-Apochromat oil-immersion objective) with the following
settings: DAPI; Blue diode 405 laser/band-pass filter 420–
480 nm, Alexa488; Argon–ion 488 laser/long-pass filter 505 nm,
Alexa 594; and HeNe 543 laser/long-pass filter 560 nm. Sections
(2.5–3 mm thick) were optically sliced (optical slice thickness of
,0.8 um) into 8–10 images that were projected on top of one
another to give the images presented.
Plasmids
The UL114 DNA sequence was PCR-amplified for cloning into
the ECORI site of the two-hybrid vector pGBKT7 (MATCH-
MAKER two-hybrid systems, Clontech) with primers: 59- CGG
AAT TCA TGG CCC TCA AGC AGT GGA TG-39 (forward)
and 59- CCC CGA ATT CAC CCA CAG AGT CGC CA-3
(reverse) and pDEST14 –UL114 [26] as a template. All clones
were confirmed by sequencing the insert on both strands.
Yeast Two-hybrid Screening
The Clontech GAL4 MATCHMAKER yeast two-hybrid
system was used according to the manufacturer’s (Clontech)
instructions. The Pretransformed MATCHMAKER brain cDNA
library (PT3183-1) were precloned into a yeast GAL4 activation
domain (AD) vector (pACT2, LEU2+), pretransformed into
Saccharomyces cerevisiae host strain Y187 (MATa, MEL1, lacZ) and
used to screen for binding partners for UL114 cloned into
pGBKT7 vector in frame to the DNA binding domain (construct
pGBKT7 -UL114) in the yeast strain Saccharomyces cerevisiae host
strain AH109 (MATa, HIS3, ADE2, MEL1, lacZ).
Figure 6. SMARCB1, UL114 and UL44 are associated with the
chromatin and the nuclear matrix in HCMV infected fibroblast
cells. Mock- and HCMV-infected fibroblast cells harvested at indicated
time points were subjected to sub-nuclear fractionation to obtain
whole chromatin fraction and core nuclear matrix. Proteins from equal
cell equivalents from each fraction were analyzed by western blotting
with the indicated antibodies.
doi:10.1371/journal.pone.0034119.g006
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immunoprecipitation
The GAL4 activation vector (AD) (pACT2) used for construct-
ing pretransformed libraries lacked both a T7 RNA polymerase
promoter and an epitope tag. By using PCR with appropriate
primers (as indicated by MATCHMAKER Co-IP kit, BD
Bioscience) we introduced T7 and HA tag sequences upstream
of the collected library cDNA while amplifying the insert for in vitro
transcription and translation. In vitro transcription/translation was
carried out using the TNTH Quick Coupled transcription/
translation system (Promega Corp.) to synthesis
35S labeled and
tagged protein according to the manufacturer’s instructions.
Following translation, co-immunoprecipitation according to the
manufacturer’s instructions (Matchmaker Co-IP kit, PT3323-1,
BD Bioscience) was carried out followed by conventional SDS-
PAGE (8% SDS–polyacrylamide) and PhoshorImager (Molecular
Dynamics).
Expression and purification of recombinant proteins
Expression and purification of UL114, His6-UL44 and His6-
NEIL1 (hFPG1) were carried out as described previously [26,69].
Human full-length SMARCB1 (Ultimate
TM ORF Clone
IOH29630, pENTR
TM221 Invitrogen) which are compatible
with the Escherichia coli (E.coli) Expression System Gateway
Technology was transferred into pDEST15 (GST-tag at the N-
terminal site) by recombination according to the manufacturer’s
protocols. E.coli BL21-AI
TM cells were transformed with
pDEST15-SMARCB1 plasmid. Cells were grown at 37uCi n
3 L of LB
amp medium containing D-Sorbitol and Betaine to an
absorbance of approximately 0.3 at 600 nm. Expression was
induced by addition of L-arabinose to a final concentration of
0.2%. Cells were grown for an additional 16 hours at 18uC and
then centrifuged at 6000 g for 20 min and stored at 220uC before
use. The thawed cell pellet was resuspended in 45 mL PSB buffer
containing 5 mM DTT, and the cells were lysed by sonication.
Next, the lysate was centrifuged at 13000 rpm for 30 min at 4uC.
The supernatant was applied directly to a 5 mL GStrap column
equilibrated in PBS containing 5 mM DTT and the tagged
protein was eluted in 50 mM Tris-HCl, pH 8.0 containing
10 mM reduced glutathione and 10 mM DTT. Fractions
containing purified protein were concentrated and further purified
by gel filtration chromatography (superdex75 equilibrated in
10 mM Tris-HCl pH 7.5, 50 mM NaCl and 10 mM b-ME).
Expression and purification of crude GST extract
E.coli BL21 codon Plus cells (BL21-CodonPlus (DE3)-RIL
strain, cat. nr. 230245, Stratagene) were transformed with
pGEX-3X (Code no: 27-4803-01, Pharmacia Biotech) to express
crude GST. The transformed cells were grown at 37uC in 0.5 L
LB medium containing 100 mg/ml ampicillin and expression of
GST was induced with 1 mM isopropyl-ß-d-thiogalactopyranoside
(IPTG) at OD600 of 0.7. The cells were harvested after four hours.
The cell pellet was resuspended in PBS with 1 mM DTT (5 ml per
g cell pellet) and cell-free extract was prepared by sonication and
centrifugation (14000 g) for 30 min.
GST pull-down assay
Crude GST-extract and purified GST-SMARCB1 were
subjected to GST pull-down analysis with the Rapid purification
of GST-Fusion Proteins kit (Cat 3 MG-101, Bioclone Inc) using
the BcMagHGST magnetic beads according to the manufacturer’s
protocol with some modifications. Briefly, 30 ml BcMag beads
were incubated with 10 mg purified recombinant GST-SMARCB1
or 50 mg crude GST-extract (negative control) for 30 min at room
temperature. Next, 20 mg purified recombinant UL114 or 3 mg of
modified RIPA lysate from mock or HCMV infected cells
harvested at 72 hpi were added to the BcMagHGST magnetic
beads. After washing in GST Binding/Washing buffer the co-
precipitate was eluted in NuPage loading buffer by heating at
70uC for 20 min. The proteins were separated by SDS-PAGE and
verified by western blot analysis.
His pull-down assay
Purified His6-UL44, His6-NEIL1, GST-SMARCB1 and GST
were subjected to conventional his-tag pull-down analysis with
DynabeadsH His-Tag Isolation & Pull-down (Cat. No 101.03D)
according to the manufacturer’s protocol (Dynal, Oslo, Norway)
with some modifications. Briefly, 12.5 ml Dynabeads were
incubated with 15 mg His6-UL44 or His6-NEIL1 in binding-buffer
(50 mM Na-Phosphate, pH 8.0, 600 mM NaCl, 50 mM Imidaz-
ole, 0.01% Tween-20). Next, the Dynabeads were incubated with
GST-SMARCB1 (20 mg) or GST (20 mg) in Pull-down buffer (
6.5 mM Na-phosphate, pH 7.4, 140 mM NaCl, 50 mM Imidaz-
ole, 0.01% Tween-20). Finally, the Dynabeads were incubated
with 60 ml His Elution buffer (300 mM Imidazole, 50 mM Na-
phosphate pH 8.0, 300 mM NaCl, 0.01% Tween-20). The eluted
proteins were analyzed by SDS-PAGE.
Supporting Information
Figure S1 In vitro binding analysis of HA-tagged clone 4
and c-myc-tagged UL114 in
35S-labeled proteins using
the TNT coupled transcription/translation system. The
proteins were transcribed and translated in vitro with
35S-
methionine in the translation mixture to generate radioactive
labeled products from vectors pACT2-clone 4 (HA-epitope) and
pGBKT7-UL114 (c-myc epitope). The translated clone 4-HA and
UL114-c-myc were immunoprecipitated with either anti-HA or
anti-c-myc-antibodies, eluted from the Protein G beads and
immunoprecipitates (10 ml) were subjected to 8% SDS-PAGE and
PhosphoImaging. Lane 1: UL114-c-myc+c-myc antibody. Lane 2:
clone 4-HA+HA-antibody. Lane 3: clone 4-HA+UL114-c-my-
c+HA-antibody. Lane 4: clone 4+UL114-c-myc+c-myc antibody.
(TIF)
Figure S2 Mock control for the antibodies UL44 and
SMARCB1 used in the co-localization studies of UL44
and SMARCB1 in HCMV-infected fibroblast cells har-
vested at 24, 48, and 72 hpi. The cells were fixed and
subjected to double-staining for UL44 (mouse Mab-UL44) and
SMARCB1 (rabbit Pab-SMARCB1) for immunofluorescence
microscopy. Secondary antibodies used for staining were: UL44
in green (anti-mouse 488) and SMARCB1 in red (anti-rabbit 594),
and cells were visualized by confocal microscopy. Co-localization
was visualized by a merge of the two microscopic determinations,
and counterstaining of the nuclei was achieved by the use of DAPI.
(TIF)
Figure S3 Control for the interaction between
SMARCB1 and UL44 using His6-NEIL1 as an irrelevant
protein. In vitro pull-down assay of GST-SMARCB1 and His6-
NEIL1. Purified GST-SMARCB1 (20 mg) or GST (20 mg)
incubated with purified His6-NEIL1 (15 mg) immobilized on
magnetic His-tag Dynabeads. Samples were analyzed by SDS-
PAGE and Coomassie blue staining. Lane 1: GST-SMARCB1+-
Dynabeads His-tag. Lane 2: His6-NEIL1+Dynabeads His-tag.
Lane 3: GST-SMARCB1+His6-NEIL1+Dynabeads His-tag. Lane
4: GST+His6-NEIL1+Dynabeads His-tag. Lane 5: GST (input,
Human Cytomegalovirus UL114 Interact with SMARCB1
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e341192 mg, 10%). Lane 6: GST-SMARCB1 (input, 2 mg, 10%). Lane 7:
His6-NEIL1 (input, 2 mg, 13%). Note that spontaneous cleavage
occurred in the GST-SMARCB1 protein sample (Lane 5).
(TIF)
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